Skip to main content
Erschienen in: European Spine Journal 11/2007

01.11.2007 | Original Article

MRI and 18FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients

verfasst von: Nadir Alexander Ghanem, Gregor Pache, Christian Lohrmann, Ingo Brink, Thorsten Bley, Elmar Kotter, Thomas Kelly, Mathias Langer

Erschienen in: European Spine Journal | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the diagnostic value of MRI and 18FDG-PET in bone marrow infiltration of the spine due to metastases of solid tumours and lymphoma in cancer patients. In 35 cancer patients (solid tumours n = 26, lymphoma n = 9) MRI of the spine and 18FDG-PET were reviewed and the detectability of metastases, infiltration of the spine, extent of disease, and therapeutic implications were compared. In 8/35 cases (23%) imaging technique showed concordantly no bone marrow infiltration. In 19/35 patients (54%), both MRI and 18FDG-PET revealed bone marrow infiltration of the axial skeleton. In 12/19 patients (63%), MRI showed more extensive disease which lead to subsequent therapy. The imaging findings of MRI and 18FDG-PET were discordant in 8/35 cases (23%). 18FDG-PET was false positive in two patients. In six patients, 18FDG-PET failed to detect bone metastases and bone marrow infiltration of the spine, which was detected by MRI and proven by clinical follow-up with subsequent therapy in two cases. MRI is more sensitive and specific than 18FDG-PET detecting bone marrow metastases and infiltration of the spine and has a great impact in staging cancer patients.
Literatur
1.
Zurück zum Zitat Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 3:336–340CrossRef Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 3:336–340CrossRef
2.
Zurück zum Zitat Altehoefer C, Blum U, Bathmann J, Wüstenberg C, Uhrmeister P, Laubenberger J, Lange W, Schwarzkopf J, Moser E, Langer M (1997) Comparative accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma. J Clin Oncol 15:1754–1760PubMed Altehoefer C, Blum U, Bathmann J, Wüstenberg C, Uhrmeister P, Laubenberger J, Lange W, Schwarzkopf J, Moser E, Langer M (1997) Comparative accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma. J Clin Oncol 15:1754–1760PubMed
3.
Zurück zum Zitat Altehoefer C, Ghanem N, Högerle S, Moser E, Langer M (2001) Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone marrow scintigraphy in patients with breast cancer. Eur J Radiol 40:16–23PubMedCrossRef Altehoefer C, Ghanem N, Högerle S, Moser E, Langer M (2001) Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone marrow scintigraphy in patients with breast cancer. Eur J Radiol 40:16–23PubMedCrossRef
4.
Zurück zum Zitat Baur A, Stäbler A, Nagel D et al (2002) Magnetic resonance imaging as a supplement for clinical staging system of Durie and Salmon ? Cancer 95:1334–45PubMedCrossRef Baur A, Stäbler A, Nagel D et al (2002) Magnetic resonance imaging as a supplement for clinical staging system of Durie and Salmon ? Cancer 95:1334–45PubMedCrossRef
5.
Zurück zum Zitat Bares R (1998) Skeletal scintigraphy in breast cancer management. Q J Nucl Med 42:43–48PubMed Bares R (1998) Skeletal scintigraphy in breast cancer management. Q J Nucl Med 42:43–48PubMed
6.
Zurück zum Zitat Brink I, Schumacher T, Mix M et al (2004) FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 31:1614–1620PubMedCrossRef Brink I, Schumacher T, Mix M et al (2004) FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 31:1614–1620PubMedCrossRef
7.
Zurück zum Zitat Cook GJ, Houston S, Rubens RD, Maisey MN, Fogelman I (1998) Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375–3379PubMed Cook GJ, Houston S, Rubens RD, Maisey MN, Fogelman I (1998) Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375–3379PubMed
8.
Zurück zum Zitat Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jurgens H, Schober O, Rummeny EJ (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG-PET. AJR Am J Roentgenol 177:229–236PubMed Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jurgens H, Schober O, Rummeny EJ (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG-PET. AJR Am J Roentgenol 177:229–236PubMed
9.
Zurück zum Zitat Fayad LM, Cohade C, Wahl RW, Fishman EK (2003) Sacral fractures: a potential pitfall of FDG-PET. AJR Am J Roentgenol 181:1239–1243PubMed Fayad LM, Cohade C, Wahl RW, Fishman EK (2003) Sacral fractures: a potential pitfall of FDG-PET. AJR Am J Roentgenol 181:1239–1243PubMed
10.
Zurück zum Zitat Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jürgens H, Schober O (2002) FDG-PET for detection of recurrences from malignant primary bone tumors and comparison with conventional imaging. Ann Oncol 13:157–160PubMedCrossRef Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jürgens H, Schober O (2002) FDG-PET for detection of recurrences from malignant primary bone tumors and comparison with conventional imaging. Ann Oncol 13:157–160PubMedCrossRef
11.
Zurück zum Zitat Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H, Schober O (2000) FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 27:1305–1311PubMedCrossRef Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H, Schober O (2000) FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 27:1305–1311PubMedCrossRef
12.
Zurück zum Zitat Ghanem N, Altehoefer C, Högerle S et al (2002) MRI and FDG-PET of the axial skeleton in cancer patients. ESSR 2002, IX Annual Meeting. pp 191–192 Ghanem N, Altehoefer C, Högerle S et al (2002) MRI and FDG-PET of the axial skeleton in cancer patients. ESSR 2002, IX Annual Meeting. pp 191–192
13.
Zurück zum Zitat Ghanem N, Altehoefer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastastic solid tumors of the axial skeleton. Eur J Radiol 43:256–261PubMedCrossRef Ghanem N, Altehoefer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastastic solid tumors of the axial skeleton. Eur J Radiol 43:256–261PubMedCrossRef
14.
Zurück zum Zitat Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF (2000) Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 20:2189–2192PubMed Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF (2000) Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 20:2189–2192PubMed
15.
Zurück zum Zitat Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413PubMed Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413PubMed
16.
Zurück zum Zitat Munker R, Hasenclever D, Brosteanu O et al (1995) Bone marrow involvement in Hodgkin`s disease: an analysis of 135 consecutive cases. J Clin Oncol 13:403–409PubMed Munker R, Hasenclever D, Brosteanu O et al (1995) Bone marrow involvement in Hodgkin`s disease: an analysis of 135 consecutive cases. J Clin Oncol 13:403–409PubMed
17.
Zurück zum Zitat Schirrmeister H, Guhlmann A, Kotzerke J et al (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17:2381–2389PubMed Schirrmeister H, Guhlmann A, Kotzerke J et al (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17:2381–2389PubMed
18.
Zurück zum Zitat Sherry MM, Greco FA, Johnson DH, Hainsworth ID (1986) Breast cancer with skeletal metastases at initial diagnosis. Distinctive clinical characteristics and favourable prognosis. Cancer 58:178–182PubMedCrossRef Sherry MM, Greco FA, Johnson DH, Hainsworth ID (1986) Breast cancer with skeletal metastases at initial diagnosis. Distinctive clinical characteristics and favourable prognosis. Cancer 58:178–182PubMedCrossRef
19.
Zurück zum Zitat Shreve PD, Barton GH, Gross MD, Wahl RL (1996) Metastatic prostate cancer: Initial findings of PET with 2-Deoxy-2-(F-18)fluoro-d1-glucose. Radiology 199:751–756PubMed Shreve PD, Barton GH, Gross MD, Wahl RL (1996) Metastatic prostate cancer: Initial findings of PET with 2-Deoxy-2-(F-18)fluoro-d1-glucose. Radiology 199:751–756PubMed
20.
Zurück zum Zitat Wikenheiser KA, Silberstein EB (1996) Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective? Clevel Clin J Med 63:43–44 Wikenheiser KA, Silberstein EB (1996) Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective? Clevel Clin J Med 63:43–44
Metadaten
Titel
MRI and 18FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients
verfasst von
Nadir Alexander Ghanem
Gregor Pache
Christian Lohrmann
Ingo Brink
Thorsten Bley
Elmar Kotter
Thomas Kelly
Mathias Langer
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
European Spine Journal / Ausgabe 11/2007
Print ISSN: 0940-6719
Elektronische ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-007-0350-x

Weitere Artikel der Ausgabe 11/2007

European Spine Journal 11/2007 Zur Ausgabe

Abstracts

Abstracts

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.